BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 7543496)

  • 1. Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis.
    Bussolino F; Arese M; Montrucchio G; Barra L; Primo L; Benelli R; Sanavio F; Aglietta M; Ghigo D; Rola-Pleszczynski MR
    J Clin Invest; 1995 Aug; 96(2):940-52. PubMed ID: 7543496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages.
    Camussi G; Montrucchio G; Lupia E; Soldi R; Comoglio PM; Bussolino F
    J Immunol; 1997 Feb; 158(3):1302-9. PubMed ID: 9013973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis.
    Biancone L; Cantaluppi V; Boccellino M; Bussolati B; Del Sorbo L; Conaldi PG; Albini A; Toniolo A; Camussi G
    Am J Pathol; 1999 Nov; 155(5):1731-9. PubMed ID: 10550329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism.
    Brizzi MF; Battaglia E; Montrucchio G; Dentelli P; Del Sorbo L; Garbarino G; Pegoraro L; Camussi G
    Circ Res; 1999 Apr; 84(7):785-96. PubMed ID: 10205146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model.
    Montrucchio G; Lupia E; Battaglia E; Del Sorbo L; Boccellino M; Biancone L; Emanuelli G; Camussi G
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):80-8. PubMed ID: 10634803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice.
    Samaniego F; Markham PD; Gendelman R; Gallo RC; Ensoli B
    J Immunol; 1997 Feb; 158(4):1887-94. PubMed ID: 9029130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor mediates CD40-dependent angiogenesis and endothelial-smooth muscle cell interaction.
    Russo S; Bussolati B; Deambrosis I; Mariano F; Camussi G
    J Immunol; 2003 Nov; 171(10):5489-97. PubMed ID: 14607955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis.
    Montrucchio G; Lupia E; Battaglia E; Passerini G; Bussolino F; Emanuelli G; Camussi G
    J Exp Med; 1994 Jul; 180(1):377-82. PubMed ID: 7516414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor stimulates interleukin-6 production by human endothelial cells and synergizes with tumor necrosis factor for enhanced production of granulocyte-macrophage colony stimulating factor.
    Lacasse C; Turcotte S; Gingras D; Stankova J; Rola-Pleszczynski M
    Inflammation; 1997 Apr; 21(2):145-58. PubMed ID: 9187959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy.
    Benelli R; Adatia R; Ensoli B; Stetler-Stevenson WG; Santi L; Albini A
    Oncol Res; 1994; 6(6):251-7. PubMed ID: 7532474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased neutrophil-endothelial adhesion induced by placental factors is mediated by platelet-activating factor in preeclampsia.
    Wang Y; Adair CD; Weeks JW; Lewis DF; Alexander JS
    J Soc Gynecol Investig; 1999; 6(3):136-41. PubMed ID: 10376269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha.
    Montrucchio G; Lupia E; de Martino A; Battaglia E; Arese M; Tizzani A; Bussolino F; Camussi G
    Am J Pathol; 1997 Aug; 151(2):557-63. PubMed ID: 9250168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells.
    Marchiò S; Primo L; Pagano M; Palestro G; Albini A; Veikkola T; Cascone I; Alitalo K; Bussolino F
    J Biol Chem; 1999 Sep; 274(39):27617-22. PubMed ID: 10488101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness.
    Thompson EW; Nakamura S; Shima TB; Melchiori A; Martin GR; Salahuddin SZ; Gallo RC; Albini A
    Cancer Res; 1991 May; 51(10):2670-6. PubMed ID: 2021945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Kaposi's sarcoma in vivo by fenretinide.
    Ferrari N; Morini M; Pfeffer U; Minghelli S; Noonan DM; Albini A
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6020-9. PubMed ID: 14676128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor (PAF) is the effector of IFN gamma-stimulated invasiveness and motility in a B16 melanoma line.
    Fallani A; Calorini L; Mannini A; Gabellieri S; Mugnai G; Ruggieri S
    Prostaglandins Other Lipid Mediat; 2006 Dec; 81(3-4):171-7. PubMed ID: 17085325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
    Cornali E; Zietz C; Benelli R; Weninger W; Masiello L; Breier G; Tschachler E; Albini A; Stürzl M
    Am J Pathol; 1996 Dec; 149(6):1851-69. PubMed ID: 8952523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin.
    Barillari G; Sgadari C; Palladino C; Gendelman R; Caputo A; Morris CB; Nair BC; Markham P; Nel A; Stürzl M; Ensoli B
    J Immunol; 1999 Aug; 163(4):1929-35. PubMed ID: 10438928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.